Robot-Assisted Technique Improves Small Kidney Tumor Removal
|
By HospiMedica International staff writers Posted on 24 Jul 2014 |
A new study demonstrates that retroperitoneoscopic partial nephrectomy (RARPN) is preferable for excising posterior kidney tumors less accessible through traditional minimally invasive surgery (MIS) approaches.
Researchers at the University of California, Los Angeles (UCLA; USA), the Swedish Medical Center (Seattle, WA, USA), and the University of Michigan (Ann Arbor, USA) conducted a retrospective multicenter study of 227 consecutive RARPNs performed between 2006 to 2013. The researchers assessed positive margins and cancer recurrence, examining factors associated with complications, estimated blood loss (EBL), warm ischemia time (WIT), operative time (OT), and length of stay (LOS). Median patient age was 60 and median body mass index (BMI) was 28.2 kg/m2.
The results showed that 28 subjects (12.3%) experienced complications, three (1.3%) had urine leaks, and three (1.3%) had pseudoaneurysms that required reintervention. Intersurgeon variation was associated with complications and WIT, with higher surgeon volume associated with shorter WIT. Higher BMI was associated with longer OT, and longer OT was associated with longer LOS. There was also a trend for intersurgeon variation in OT. The study was published online on May 21, 2014, in European Urology.
“RARPN has acceptable morbidity and oncologic outcomes, despite intersurgeon variation in WIT and complications. These differences in warm ischemia time may be attributable to slight variations in surgical technique,” said lead author Jim Hu, MD, of the UCLA Jonsson Comprehensive Cancer Center. “But we showed center-specific variations in the RARPN approach and we present a video on surgical technique to highlight our approach.”
Small renal masses are a heterogeneous group of tumors, and only 20% are aggressive renal cell carcinoma. In general, nephron-sparing treatments are preferred to avoid chronic kidney disease (CKD), which often occurs after radical nephrectomy. RARPN, thermal ablation, and active surveillance are all valid treatment strategies in select patients who are not optimal surgical candidates or who have limited life expectancy.
WIT refers to the amount of time the renal artery, the main blood supply to the kidney, is blocked off during surgery. Longer WITs are associated with increased complications, such as acute kidney failure and long-term CKD.
Related Links:
University of California, Los Angeles
Swedish Medical Center
University of Michigan
Researchers at the University of California, Los Angeles (UCLA; USA), the Swedish Medical Center (Seattle, WA, USA), and the University of Michigan (Ann Arbor, USA) conducted a retrospective multicenter study of 227 consecutive RARPNs performed between 2006 to 2013. The researchers assessed positive margins and cancer recurrence, examining factors associated with complications, estimated blood loss (EBL), warm ischemia time (WIT), operative time (OT), and length of stay (LOS). Median patient age was 60 and median body mass index (BMI) was 28.2 kg/m2.
The results showed that 28 subjects (12.3%) experienced complications, three (1.3%) had urine leaks, and three (1.3%) had pseudoaneurysms that required reintervention. Intersurgeon variation was associated with complications and WIT, with higher surgeon volume associated with shorter WIT. Higher BMI was associated with longer OT, and longer OT was associated with longer LOS. There was also a trend for intersurgeon variation in OT. The study was published online on May 21, 2014, in European Urology.
“RARPN has acceptable morbidity and oncologic outcomes, despite intersurgeon variation in WIT and complications. These differences in warm ischemia time may be attributable to slight variations in surgical technique,” said lead author Jim Hu, MD, of the UCLA Jonsson Comprehensive Cancer Center. “But we showed center-specific variations in the RARPN approach and we present a video on surgical technique to highlight our approach.”
Small renal masses are a heterogeneous group of tumors, and only 20% are aggressive renal cell carcinoma. In general, nephron-sparing treatments are preferred to avoid chronic kidney disease (CKD), which often occurs after radical nephrectomy. RARPN, thermal ablation, and active surveillance are all valid treatment strategies in select patients who are not optimal surgical candidates or who have limited life expectancy.
WIT refers to the amount of time the renal artery, the main blood supply to the kidney, is blocked off during surgery. Longer WITs are associated with increased complications, such as acute kidney failure and long-term CKD.
Related Links:
University of California, Los Angeles
Swedish Medical Center
University of Michigan
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







